Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Boost

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Arzneimittel-Forschung|February 1, 1975
[Long-term therapy of progressive chronic polyarthritis with naproxen]G Boost
Arzneimittel-Forschung|February 1, 1975
[Clinical-pharmacological and pharmacokinetic studies with naproxen]G Boost
Journal of Clinical Pharmacology|April 1, 1975
An open trial of naproxen in rheumatoid arthritis patients with significant esophageal, gastric, and duodenal lesionsS H Roth, G Boost
Journal of Pharmaceutical Sciences|May 1, 1972
Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjectsR Runkel, M Chaplin, G Boost, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1972
Lysosomal concept of menstrual bleeding in humansM R Henzl, R E Smith, G Boost, et al.
International Journal of Clinical Pharmacology, Therapy and Toxicology|February 1, 1973
Methoxypropriocin (RS-3540); clinical study on 40 patients suffering from rheumatoid arthritisA Lussier, D Regoli, E Gysling, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1973
Long term study of naproxen challenged by a short-term double blind cross-over study with placebo in rheumatoid patientsA Lussier, D Myhal, G Boost, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1973
Naproxen-metabolism, excretion and comparative pharmacokineticsR Runkel, E Forchielli, G Boost, et al.
Chemical & Pharmaceutical Bulletin|July 1, 1972
Naproxen oral absorption characteristicsR A Runkel, K S Kraft, G Boost, et al.
Clinical Pharmacology and Therapeutics|May 1, 1973
Naproxen: a novel approach to dose-finding efficacy trails in rheumatoid arthritisA Lussier, E J Segre, C V Multz, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Arzneimittel-Forschung|February 1, 1975
[Long-term therapy of progressive chronic polyarthritis with naproxen]G Boost
Arzneimittel-Forschung|February 1, 1975
[Clinical-pharmacological and pharmacokinetic studies with naproxen]G Boost
Journal of Clinical Pharmacology|April 1, 1975
An open trial of naproxen in rheumatoid arthritis patients with significant esophageal, gastric, and duodenal lesionsS H Roth, G Boost
Journal of Pharmaceutical Sciences|May 1, 1972
Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjectsR Runkel, M Chaplin, G Boost, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1972
Lysosomal concept of menstrual bleeding in humansM R Henzl, R E Smith, G Boost, et al.
International Journal of Clinical Pharmacology, Therapy and Toxicology|February 1, 1973
Methoxypropriocin (RS-3540); clinical study on 40 patients suffering from rheumatoid arthritisA Lussier, D Regoli, E Gysling, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1973
Long term study of naproxen challenged by a short-term double blind cross-over study with placebo in rheumatoid patientsA Lussier, D Myhal, G Boost, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1973
Naproxen-metabolism, excretion and comparative pharmacokineticsR Runkel, E Forchielli, G Boost, et al.
Chemical & Pharmaceutical Bulletin|July 1, 1972
Naproxen oral absorption characteristicsR A Runkel, K S Kraft, G Boost, et al.
Clinical Pharmacology and Therapeutics|May 1, 1973
Naproxen: a novel approach to dose-finding efficacy trails in rheumatoid arthritisA Lussier, E J Segre, C V Multz, et al.
Pageof 1